NCT00787566: Phase 2 Study of Efficacy, Tolerability, and Safety of Intranasal Granisetron for Chemo-Induced Nausea and Vomiting |
|
|
| Completed | 2 | 68 | US | Intranasal granisetron, TRG | Shin Nippon Biomedical Laboratories, Ltd. | Chemotherapy-Induced Nausea and Vomiting | 04/09 | 05/09 | | |